Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Carson CF"" wg kryterium: Autor


Tytuł:
Uncontrolled, open-label, pilot study of tea tree (Melaleuca alternifolia) oil solution in the decolonisation of methicillin-resistant Staphylococcus aureus positive wounds and its influence on wound healing.
Autorzy:
Edmondson M
Newall N
Carville K
Smith J
Riley TV
Carson CF
Pokaż więcej
Źródło:
International Wound Journal; Aug2011, Vol. 8 Issue 4, p375-384, 10p
Czasopismo naukowe
Tytuł:
Antiparasitic Activity of Tea Tree Oil (TTO) and Its Components against Medically Important Ectoparasites: A Systematic Review.
Autorzy:
Bezabh SA; Faculty of Health, University of Canberra, Bruce, Canberra, ACT 2617, Australia.; Department of Pharmaceutics, School of Pharmacy, College of Health Sciences, Mekelle University, Mekelle 7000, Ethiopia.
Tesfaye W; Faculty of Health, University of Canberra, Bruce, Canberra, ACT 2617, Australia.; School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2050, Australia.
Christenson JK; Faculty of Health, University of Canberra, Bruce, Canberra, ACT 2617, Australia.
Carson CF; School of Medicine, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.
Thomas J; Faculty of Health, University of Canberra, Bruce, Canberra, ACT 2617, Australia.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2022 Jul 29; Vol. 14 (8). Date of Electronic Publication: 2022 Jul 29.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Human pleural fluid is a potent growth medium for Streptococcus pneumoniae.
Autorzy:
Popowicz ND; Pharmacy Department, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.; Division of Medicine, University of Western Australia, Perth, Western Australia, Australia.; Institute for Respiratory Health, University of Western Australia, Perth, Western Australia, Australia.
Lansley SM; Institute for Respiratory Health, University of Western Australia, Perth, Western Australia, Australia.
Cheah HM; Institute for Respiratory Health, University of Western Australia, Perth, Western Australia, Australia.
Kay ID; Department of Microbiology and Infectious Diseases, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, Western Australia, Australia.
Carson CF; Division of Medicine, University of Western Australia, Perth, Western Australia, Australia.
Waterer GW; Division of Medicine, University of Western Australia, Perth, Western Australia, Australia.; Respiratory Department, Royal Perth Hospital, Perth, Western Australia, Australia.
Paton JC; Research Centre for Infectious Diseases, Department of Molecular and Cellular Biology, University of Adelaide, Adelaide, South Australia, Australia.
Brown JS; Centre for Inflammation and Tissue Repair, Respiratory Medicine, University College London, London, England.
Lee YCG; Division of Medicine, University of Western Australia, Perth, Western Australia, Australia.; Institute for Respiratory Health, University of Western Australia, Perth, Western Australia, Australia.; Respiratory Department, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Nov 30; Vol. 12 (11), pp. e0188833. Date of Electronic Publication: 2017 Nov 30 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Empyema, Pleural/*microbiology
Pleural Effusion/*microbiology
Streptococcus pneumoniae/*growth & development
Humans ; Streptococcus pneumoniae/pathogenicity
Czasopismo naukowe
Tytuł:
Analysis of early mesothelial cell responses to Staphylococcus epidermidis isolated from patients with peritoneal dialysis-associated peritonitis.
Autorzy:
McGuire AL; Translational Renal Research Group, Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.; School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.
Mulroney KT; Translational Renal Research Group, Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.; School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.
Carson CF; Translational Renal Research Group, Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.; School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.
Ram R; Centre for Diabetes Research, Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.
Morahan G; Centre for Diabetes Research, Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.
Chakera A; Translational Renal Research Group, Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.; School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.; Department of Renal Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 May 24; Vol. 12 (5), pp. e0178151. Date of Electronic Publication: 2017 May 24 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Peritoneal Dialysis/*adverse effects
Peritonitis/*etiology
Peritonitis/*microbiology
Staphylococcal Infections/*etiology
Staphylococcal Infections/*microbiology
Staphylococcus epidermidis/*pathogenicity
Cell Line ; Cells, Cultured ; Epithelial Cells/immunology ; Epithelial Cells/microbiology ; Gene Expression ; Host-Pathogen Interactions/genetics ; Host-Pathogen Interactions/immunology ; Humans ; Interleukin-17/genetics ; Peritoneal Cavity/microbiology ; Peritonitis/genetics ; Receptors, Tumor Necrosis Factor, Type I/genetics ; Receptors, Tumor Necrosis Factor, Type II/genetics ; Signal Transduction/genetics ; Signal Transduction/immunology ; Staphylococcal Infections/genetics ; Staphylococcus epidermidis/isolation & purification ; Virulence
Czasopismo naukowe
Tytuł:
In vitro data support the investigation of vinegar as an antimicrobial agent for PD-associated Pseudomonas exit site infections.
Autorzy:
Carson CF; School of Medicine and Pharmacology, The University of Western Australia (M503), Crawley, Australia.; Translational Renal Research Group, Harry Perkins Institute of Medical Research, Nedlands, Australia.
Ash O; School of Medicine, The University of Notre Dame Australia, Fremantle, Australia.
Chakera A; School of Medicine and Pharmacology, The University of Western Australia (M503), Crawley, Australia.; Translational Renal Research Group, Harry Perkins Institute of Medical Research, Nedlands, Australia.; Renal Unit, Sir Charles Gairdner Hospital, Nedlands, Australia.
Pokaż więcej
Źródło:
Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2017 Feb; Vol. 22 (2), pp. 179-181.
Typ publikacji:
Journal Article
MeSH Terms:
Acetic Acid/*pharmacology
Anti-Infective Agents/*pharmacology
Peritoneal Dialysis/*adverse effects
Peritonitis/*drug therapy
Pseudomonas/*drug effects
Pseudomonas Infections/*drug therapy
Drug Resistance, Bacterial ; Humans ; Microbial Sensitivity Tests ; Peritonitis/microbiology ; Pseudomonas/classification ; Pseudomonas/isolation & purification ; Pseudomonas Infections/microbiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies